Galectin Therapeutics, Inc.(GALT)- NASDAQ
From other sites
Company Description
Galectin Therapeutics, Inc. operates as a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease and cancer. Its drug candidates are based on the method of targeting galectin proteins, which are key mediators of biologic and pathologic... More
Sector: Healthcare
Industry: Drugs - Generic
Country: United States